Bloomberg Businessweek cover image

Lilly Is Selling Zepbound Vials at 50% Discount to Shots

Bloomberg Businessweek

00:00

Intro

This chapter explores Eli Lilly's novel approach to distributing its weight loss drug ZEPBOWN, allowing patients to self-fill vials at a monthly cost of $399. It discusses the potential benefits and challenges of this self-administration method in response to supply shortages and patient preferences.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app